• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Vasomotor Symptoms Companies

    ID: MRFR/HC/8332-HCR
    153 Pages
    Rahul Gotadki
    October 2025

    Addressing women's health, Vasomotor Symptoms companies focus on solutions for menopausal symptoms. Through research and innovation, they offer therapies to alleviate vasomotor symptoms like hot flashes and night sweats, enhancing the quality of life for women transitioning through menopause.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Vasomotor Symptoms Market Research Report - Forecast till 2032 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Vasomotor Symptoms Market

    Vasomotor Symptoms Key Companies

     


    Latest Vasomotor Symptoms Companies Update:

    Astellas' VEOZATM Received EU approval in December 2023 and US FDA approval in May 2023 for treating moderate to severe VMS due to menopause.First non-hormonal neurokinin 3 (NK3) receptor antagonist approved for VMS, offering a new option for women seeking non-hormonal treatment.


    Abbott's Upledity Launched in the US in November 2023 for moderate to severe VMS and other menopausal symptoms. Offers a new low-dose oral hormonal option for some women.


    Therapeutics Unlimited's Zyla Received FDA approval in November 2023 for the treatment of menopausal symptoms, including VMS. Offers a new topical estrogen option for women seeking to avoid systemic treatments.


    List of Vasomotor Symptoms Key companies in the market

    • Allergan (Ireland)

    • Pfizer Inc. (US)

    • Eli Lily and Company (US)

    • Novartis AG (Switzerland)

    • Emcure Pharmaceuticals Ltd (India)

    • Merck & Co.Inc. (US)

    • TherapeuticsMD Inc. (US)

    • Mithra Pharmaceuticals (Belgium)